Jennerex, a cancer biotherapeutics company, has appointed James M. Burke, M.D., vice president, clinical research. Dr. Burke will be responsible for global clinical research activities related to Jennerex pipeline compounds.

Dr. Burke brings 20 years of experience in basic and applied clinical science of genetic and immunotherapy. Previously, Dr. Burke was Director of Cancer Research at Billings Clinic, where he also was a clinical investigator for JX-594. He also was associate director of clinical research at Cell Genesys, where he was responsible for the development of the oncolytic adenovirus platform of agents and other gene therapy vaccines for the treatment of cancer and other diseases. He also worked as an attending physician at UC San Francisco in the department of hematology and oncology.